Chong Ock Lee Selected Research

KRCA-386

5/2016

Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chong Ock Lee Research Topics

Disease

17	Neoplasms (Cancer) 06/2021 - 01/2003
5	Stomach Neoplasms (Stomach Cancer) 01/2018 - 12/2011
3	Melanoma (Melanoma, Malignant) 04/2006 - 04/2003
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Carcinogenesis 01/2018
1	Brain Neoplasms (Brain Tumor) 05/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2016
1	Breast Neoplasms (Breast Cancer) 09/2015
1	Colorectal Neoplasms (Colorectal Cancer) 04/2012
1	Lung Neoplasms (Lung Cancer) 04/2012
1	Leukemia L1210 06/2004
1	Cardiotoxicity 02/2003
1	Glioma (Gliomas) 01/2003

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 05/2016 - 12/2011
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2015
2	ceritinibIBA 01/2017 - 05/2016
2	CrizotinibIBA 05/2016 - 08/2015
2	Liposomes (Liposome)IBA 09/2015 - 04/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 04/2006
1	antineoplaston A10 (A 10)IBA 06/2021
1	snake venom protein C activatorIBA 12/2020
1	Androgen Receptors (Androgen Receptor)IBA 12/2020
1	Proteolysis Targeting ChimeraIBA 12/2020
1	Biological ProductsIBA 12/2020
1	CytokinesIBA 01/2018
1	Folate Receptor 1IBA 01/2018
1	AntigensIBA 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	aristoyagonineIBA 01/2018
1	KRCA-386IBA 05/2016
1	KRC-00715IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	pyrimidineIBA 01/2016
1	MorpholinosIBA 01/2016
1	EnzymesIBA 01/2016
1	Pharmaceutical PreparationsIBA 09/2015
1	1,1'- (4,4'- (((5- chloropyrimidine- 2,4- diyl)bis(azanediyl))bis(3- methoxy- 4,1- phenylene))bis(piperazine- 4,1- diyl))diethanoneIBA 08/2015
1	PyrimidinesIBA 01/2014
1	alkoxyl radicalIBA 01/2014
1	TriazinesIBA 01/2014
1	KRC-108IBA 04/2012
1	Heparin (Liquaemin)FDA LinkGeneric 04/2006
1	Cisplatin (Platino)FDA LinkGeneric 06/2004
1	PlatinumIBA 06/2004
1	Carboplatin (JM8)FDA LinkGeneric 06/2004
1	HematoporphyrinsIBA 06/2004
1	oleananeIBA 05/2004
1	DisaccharidesIBA 05/2004
1	lissamine rhodamine B (sulforhodamine B)IBA 11/2003
1	Epoxy Compounds (Epoxides)IBA 04/2003
1	SesquiterpenesIBA 04/2003
1	LactonesIBA 04/2003
1	xanthatinIBA 04/2003
1	KR30031IBA 02/2003
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2003
1	Carmustine (FIVB)FDA Link 01/2003

Therapy/Procedure

4	Therapeutics 04/2016 - 01/2003
1	Castration 12/2020
1	Drug Therapy (Chemotherapy) 09/2015
1	Induced Hyperthermia (Thermotherapy) 09/2015
1	Intravenous Injections 04/2006